Abstract
Brain death (BD) should be understood as the ultimate clinical expression of a brain catastrophe characterized by a complete and irreversible neurological stoppage, recognized by irreversible coma, absent brainstem reflexes, and apnea. The most common pattern is manifested by an elevation of intracranial pressure to a point beyond the mean arterial pressure, and hence cerebral perfusion pressure falls and, as a result, no net cerebral blood flow is present, in due course leading to permanent cytotoxic injury of the intracranial neuronal tissue. A second mechanism is an intrinsic injury affecting the nervous tissue at a cellular level which, if extensive and unremitting, can also lead to BD. We review here the methodology of diagnosing death, based on finding any of the signs of death. The irreversible loss of cardio-circulatory and respiratory functions can cause death only when ischemia and anoxia are prolonged enough to produce an irreversible destruction of the brain. The sign of such loss of brain functions, that is to say BD diagnosis, is fully reviewed.
Key words: brain death, signs of death, brain death criteria, transcranial Doppler, EEG, multimodality evoked potentials, CT angiography.
Introduction
Long before modern technology, everyone agreed that death occurred when heartbeat and breathing ceased, and the soul abandoned the body. Nonetheless, a new concept of death evolved as technology progressed, forcing medicine and society to redefine the ancient cardio-respiratory diagnosis to a neurocentric diagnosis of death.1–4 In the meantime, the technical and scientific advances of the last century provided effective mechanical ventilators, and cardiopulmonary resuscitation (“reanimation”) compelled physicians in the late 1950s to confront a condition impossible even to imagine previously, a state in which the brain is massively damaged and nonfunctional while other organs remain functioning. Was such a patient alive or dead? This radically changed the course of the debates about human death, marking a turning point when brain-oriented definitions of death started to be formulated, and brain death (BD) was gradually accepted as death of the individual.5–12 However, it is commonly believed that the concept of BD evolved to benefit organ transplantation. A historical approach demonstrates that both brain death and transplantation had fully separate origins. Organ transplantation became possible with technical advances in surgery and immunosuppressive treatment. The concept of BD evolved with the introduction of intensive care units.12,13
BD should be understood as the ultimate clinical expression of a brain catastrophe leading to a complete and irreversible neurological stoppage, characterized by irreversible coma, absent brainstem reflexes, and apnea.14 Most authors affirm that the diagnosis of BD is just a clinical assessment, and after the Harvard Committee Report,15,16 most countries and states designed their BD diagnostic criteria.6,7,17–21 BD diagnosis should be carried out following a certain set of principles; that is to say, excluding major confusing factors, establishing the cause of the coma, determining irreversibility, and precisely testing brainstem reflexes at all levels of the brainstem.22
Pathophysiology of brain death
Increased intracranial pressure (ICP) is considered the most important pathophysiological mechanism of BD leading to a complete cessation of intracranial blood flow. Upholding of oxygenation and hemodynamics by vasopressor drugs as well as mechanical ventilation can sustain somatic organs while the brain suffers an ongoing necrosis process. However, this is not the only pathophysiological mechanism of BD.1,23 Palmer and Bader studied a series of brain-dead patients by brain tissue oxygenation (PbtO2) and described two pathophysiological patterns regarding cerebral blood flow (CBF).23,24 The most common pattern is manifested by an elevation of ICP to a point beyond the mean arterial pressure (MAP), and hence cerebral perfusion pressure (CPP) falls to zero and, as a result, no net CBF is present, in due course leading to permanent cytotoxic injury of the intracranial neuronal tissue.
In addition, there may be circumstances where an ICP increment does not lead to CBF cessation. This may occur when ICP augmentation is compensated in infants with open fontanelles and soft, deformable skulls, and in patients whose skulls are open owing to multiple fractures, ventricular drainage, or decompressive craniectomy.25–35 Moreover, diffuse intracranial parenchymal swelling is the main reason for a markedly elevated ICP, but swelling is not an indefinite phenomenon, and it may decrease progressively, and if MAP is maintained at reasonable values, CBF might ultimately return.25,28
The second pattern described by Palmer and Bader is characterized by preserved CBF, because normal ICP does not exceed MAP, and sufficient CPP is maintained leading to CBF preservation, which supplies the nervous tissue with necessary oxygen, glucose, and nutrients to permit its survival.24 In this pattern the mechanism causing PbtO2 to fall to zero is an intrinsic catastrophe affecting the nervous tissue at a cellular level which, if extensive and unremitting, can also lead to BD.23,25,36 It is clear that in this pattern the lack of oxygenation of the brain is not a failure of the delivery system, and hence it stands for end organ breakdown of the brain at the capillary or tissue level.23,36
Diagnosis of brain death
BD diagnosis should be carried out following a certain set of principles;6,21,37–46 that is to say, excluding major confusing factors, establishing the cause of the coma, determining irreversibility, and precisely testing brainstem reflexes at all levels of the brainstem.47 Nonetheless, most criteria for BD diagnosis do not mention that this is not the only way of diagnosing death. If a concept of death on neurological grounds is accepted, then BD diagnostic criteria can be applied only in patients under life support assistance in ICUs. Does it mean that when a physician diagnoses death in a regular ward (the patient is not under life support), applying cardio-circulatory and respiratory diagnostic criteria, or when a forensic specialist diagnoses death in a body under criminal circumstances, we are denying a brain-oriented concept of death?1,48
Recently Cuba has passed a law for the determination and certification of death. The National Commission for the Determination and Certification of Death has accepted a neurological view of death and emphasized that any legislation of death should be completely separated from any norm governing organ transplants.49–52 Hence, the Commission enumerated three possible situations for diagnosing death:
Outside the intensive care environment (without life support), physicians apply the cardio-circulatory and respiratory criteria.
In forensic medicine circumstances, physicians utilize cadaveric signs. (They do not even need a stethoscope.)
In the intensive care environment (with life support) when cardio-circulatory and/or respiratory arrest occurs, physicians utilize the cardio-circulatory and respiratory criteria. When physicians suspect an irreversible loss of brain functions in a heart-beating and ventilatory supported case, BD diagnostic criteria are applied.
This methodology of diagnosing death, based on finding any of the signs of death, is not related to the concept that there are different types of death. The irreversible loss of cardio-circulatory and respiratory functions can cause death only when ischemia and anoxia are prolonged enough to produce an irreversible destruction of the brain. According to the Commission, there is only one kind of death, based on the irreversible loss of brain functions.1,48–52
Signs of death
The diagnosis of death was based on the finding of any of the following signs of death:
Irreversible loss of respiratory function.
Irreversible loss of cardio-circulatory functions.
Algor mortis (postmortem coldness).
Livor mortis (postmortem lividity).
Rigor mortis (postmortem rigidity).
Cadaveric spasm.
Loss of muscle contractions.
Putrefaction.
Irreversible loss of brain functions.
Signs I and II correspond to the classical respiratory and cardio-circulatory functions. Signs III to VIII are related to forensic circumstances, and beyond the scope of this review.
Irreversible loss of brain functions (diagnosis of brain death)
As has already been emphasized, when physicians suspect an irreversible loss of brain functions in a heart-beating and ventilatory supported case, BD diagnostic criteria are applied. To assess brain functions during BD diagnosis, the clinical neurological examination is the accepted standard.8,12,13,22,48,52–54
Preconditions or pre-requisites
Coma owing to irreversible acute brain damage of known etiology, affecting both hemispheres and brainstem. What is demanded is to have clear and definite clinical and/or neuroimaging evidence of an acute central nervous system (CNS) insult that is consistent with the irreversible loss of neurological function.1,7,22,47,55
-
At the time of beginning the neurological examination, it is essential to exclude confounding factors that mimic BD:1,22,56,57
Unresuscitated shock. This is indispensable to applied BD criteria only when blood pressure has a minimum value of 90 mm Hg.22,58–62 Hypothermia (core temperature <34°C). An inability to regulate temperature, or poikilothermia, is often present in BD. Core temperature results should be obtained through central blood, rectal, esophageal, or gastric measurement. Most sets of criteria for BD diagnosis demand a body temperature of at least 32.2°C.1,17,22,43,55,61–64
Severe metabolic disorders capable of causing a potentially reversible coma. Severe metabolic or endocrine abnormalities make BD unreliable.22,55–57,65 Metabolic or endocrine derangement including glucose, electrolytes (including phosphate, calcium, and magnesium), inborn errors of metabolism, liver or renal dysfunction, etc. may cause a potentially reversible coma.1,22
Peripheral nerve or muscle dysfunction and neuromuscular blockade potentially play a role in inducing unresponsiveness in patients, and it could be a confounding factor in BD diagnosis.66–72
Clinically significant drug intoxications (e.g. alcohol, barbiturates, sedatives, hypnotics). CNS-depressant drugs should be ruled out if the clinical history is indicative.55,72–76 Clinicians in the emergency department are often confronted with coma patients owing to poisoning or intoxication. Several authors recommend using naloxone in a titrated way when an opiate intoxication is suspected.77 In the same way, flumazenil has been advocated as a benzodiazepine antagonist in coma of unknown etiology.77,78
Diagnostic criteria
Deep unresponsive coma. The diagnosis of deep unresponsive coma demands a comatose patient showing a lack of spontaneous movements in addition to an absence of motor responses mediated by stimuli applied within the cranial nerve distribution.17,22,47,49,53,65 CNS-mediated motor response to pain in any other distribution, seizures, and decorticate and decerebrate responses impede BD diagnosis. Some brain-dead individuals may present spinal reflexes or motor responses, confined to spinal distribution, which do not preclude the BD diagnosis.22,55,61,62,79,80
-
Absent brainstem reflexes. The reflexes mediated by the cranial nerves are main indicators of brainstem function. Hence, to prove their absence is indispensable to BD diagnosis. The individual significance of each brainstem reflex varies in BD diagnosis according to an intrinsic sensitivity of the cranial nerve networks and to the effect of some accompanying factors in brain-dead patients, such as trauma, local edema, dried tissues, and intracranial tubes affecting the exploration of reflexes.17,79
Pupillary reflex. This reflex, direct and consensual, is considered one of the most discriminant reflexes in BD diagnosis.17,22,55,57,61,62,79,81 Mydriatic, small, or medium-sized pupils are found in brain-dead cases.17,43,63,64
Corneal reflex. Unilateral corneal stimulation with a throat swab induces a bilateral closure of the eyelids, is an easy response to elicit and, if present, is readily observed. This is also one of the most discriminant reflexes in BD diagnosis. A bilateral or unilateral response of eyelid closure and upward deviation of the eye (Bell’s phenomenon) indicates preserved brainstem functioning. However, edema or drying of the cornea, and severe facial and ocular trauma may preclude a satisfactory stimulus for this reflex. Moreover, the threshold for excitation decreases markedly if the lids are kept closed.1,4,17,22,47,79,82,83
Oculo-cephalic and oculo-vestibular responses. The oculocephalic reflex, also known as Doll’s eyes response, is elicited upon brisk turning of the head from middle position to 90° on both sides. In comatose patients without lesions of the brainstem, the eyes normally conjugately deviate to the other side. In BD no eye movements are observed. The neural pathways of this reflex are mediated through arcs involving the vestibular mechanisms, medial longitudinal bundle, and ocular nerves. This is a reflex easy to obtain and moderately discriminative. The oculo-vestibular response is elicited by irrigating the tympanum in both sides with iced water. In a comatose patient without lesions of the medial longitudinal bundle, and/or ocular nerves, the elicited response is a slow deviation of the eyes directed to the cold caloric stimulus. The head of the patient should be elevated 30° above the horizontal plane, and 50 cc of iced water is irrigated into the external auditory canal using a small suction catheter. To confirm lack of eye movement may be very difficult; it has been suggested pen marks are placed on the lower eyelid at the level of the pupil to facilitate the detection of slight eye movements. The examiner should observe for one minute after irrigation, and wait an interval of five minutes before stimulating the opposite side. It is essential that the examiner confirm that the external auditory foramen and tympanic membrane are undamaged, because clotted blood or cerumen in the external auditory canal may impair this response. Moreover, a rupture of the eardrum usually augments caloric responses. The presence of severe facial and ocular trauma, eyelid edema, and chemosis of the conjunctiva may limit movement of the globes, making it very difficult to elicit and observe eye movements. Basal fracture of the petrous bone abolishes the caloric response unilaterally and may be identified by the presence of an ecchymotic mastoid process (Battle’s sign). There are also some drugs that can lessen this reflex, such as tricyclic antidepressants, aminoglycosides, antiepileptic drugs, anticholinergics, and chemotherapeutic agents, etc.1,6,48,62
Gag and cough response. Pharyngeal (gag), cough, and swallowing reflexes are often difficult to explore because of the presence of tubes in the throat and dryness of the mucosa. Hence, in suspected brain-dead cases the cough response is usually explored by passing a catheter through the endotracheal tube and suctioning with negative pressure for several seconds. As these reflexes have their arcs through the medulla oblongata, it is desirable to explore them.17,22,64,84
Negative atropine test. The atropine test (AtT) assesses bulbar parasympathetic activity on heart activity in brain-dead patients.85 Ouaknine first proposed including this as a criterion for the so-called brainstem death.85–89 The method for this test consists in injecting 2 mg atropine under continuous monitoring of the ECG during 10 minutes. The AtT is considered negative if heart rate is not augmented by more than 3% compared with basal ECG records.1,58,86,90–95
Absent respiratory effort confirmed by the apnea test. The apnea test (AT) has been considered by some authors as the “condition sine qua non” for determining BD, because it provides an essential sign of a definitive loss of brainstem functions. Nonetheless, several authors have expressed their concern about the safety of this procedure, owing to potential complications such as severe hypotension, pneumothorax, excessive hypercarbia, hypoxia, acidosis, cardiac arrhythmia, or asystole, which may constrain the examiner to abort the test, thereby compromising BD diagnosis. Nevertheless, when an appropriate oxygen-diffusion procedure is used, this technique is safe.1,96–105
-
Periods of observation. If BD determination is only based on clinical evaluation, the following periods of observation were proposed by the Cuban Commission.1,49–52
Six hours at least, if a structural and irreversible CNS insult can be demonstrated by clinical and neuroimaging evidences.
In cases of acute hypoxic-ischemic brain injury, clinical evaluation should be delayed for 24 hours subsequent to the cardio-respiratory arrest, or an ancillary test could be performed.
Periods of observation can be shortened according to medical criteria by the application of confirmatory tests, to demonstrate a complete cessation of brain circulation, or to demonstrate loss of bioelectrical activity.
Confirmatory tests
It is widely accepted that BD is a clinical diagnosis, and currently it is defined as a complete and irreversible loss of brain function. Confirmatory laboratory tests are recommended when specific components of the clinical testing cannot be evaluated reliably.50,51,106 Sometimes the apnea test cannot be performed or it must be interrupted by the examiner. Eye injuries may impede an appropriate assessment of pupillary, corneal, or vestibulo-reflex testing. In those patients with perforated tympanic membranes iced water caloric irrigation for exploring the vestibulo-ocular reflexes is proscribed. Furthermore, the diagnosis of BD in children and neonates is more complicated and usually ancillary tests are advocated.57,98,107–111
Confirmatory tests are recommended to shorten periods of observation according to physicians’ criteria and in those conditions interfering with the clinical BD diagnosis. The Cuban Commission proposed that confirmatory tests should be mandatory in cases of patients with primary brainstem lesions undergoing BD diagnosis.1,49–51
Confirmatory tests in BD can be divided into those proving absent CBF and those that demonstrate loss of bioelectrical activity.
Tests to demonstrate absent cerebral blood flow
Bernat recently emphasized that “the most confident way to demonstrate that the global loss of clinical brain functions is irreversible is to show the complete absence of intracranial blood flow.”112 Ingvar and colleagues defended this, concluding that the permanent cessation of CBF produces total brain infarction.113,114
Several tests that can measure CBF accurately and validly in suspected brain-dead patients have been developed in the last decades. The first technique used to demonstrate absence of intracranial circulation in BD distal to the intracranial portions of the internal carotid and vertebral arteries was cerebral angiography.115–117 Other techniques used to determine absent CBF have been: cerebral intravenous digital subtraction angiography, intravenous radionuclide angiography, single photon emission tomography (SPECT), echoencephalography, measurement of arm-to-retina circulation time, ophthalmic artery pressure measurement, xenon-enhanced computed tomography, MRI angiography, CT angiography and CT perfusion, and transcranial Doppler ultrasonography (TCD).
Although it has not been widely used as an ancillary test in BD, the 18F-FDG PET scan has been used by some authors to study brain-dead patients, and confirmed no intracerebral uptake or retention of tracer, consistent with a diffuse absence of brain metabolism.118,119
Another technique that could be useful in monitoring biochemical changes in vivo, from coma to BD, is proton magnetic resonance spectroscopy (1H-MRS). N-acetyl aspartate (NAA) content is a measure of neuronal integrity, choline (Cho) content mirrors membrane turnover, and creatine (Cre) relates to energy dependent systems. Falini et al. serially studied a patient with severe global hypoxicischemic brain injury using 1H-MRS. Particularly notable was a quick decline of NAA in the acute phase, suggesting the severity of the neuronal insult, and after seven weeks of evolution the irreversible death of the major part of the neuronal population was confirmed.120 We have also applied this technique to monitor metabolic changes in the evolution from a persistent vegetative state to a minimally conscious state.121
TCD has been recommended for assessing CBF in suspected brain-dead patients.122–128 TCD is a noninvasive technique that measures local blood flow velocity and direction in the proximal portions of large intracranial arteries. TCD requires training and experience to perform it and interpret results; hence, it is typified as operator-dependent.129,130 In the ICU setting, intensivists or neurologists usually receive training to apply this technique using portable Doppler devices in suspected brain-dead cases. Oscillating flow, systolic spikes, or no flow patterns are typical Doppler-sonographic flow signals found in the presence of cerebral circulatory arrest, which if irreversible, results in BD.1,131,132
Nonetheless, recent reports affirmed that multi-slice CT angiography (CTA) is a robust tool to demonstrate the lack of intracranial blood flow, showing a high sensitivity and a wide safety margin for diagnosing BD. In the near future it might be the preferred test for proving CBF.29,124,133
Tests to demonstrate loss of bio-electrical activity
The EEG has been closely linked to BD since the pioneering descriptions of the death of the nervous system and coma dépassé.134,135 The set of criteria based on a brainstem standard, like those from the Commonwealth countries, does not include EEG.3–5,136–140 On the contrary, EEG is recommended by most countries adopting the “whole brain death” definition.141–145
Although EEG is sensitive to hypothermia, drugs, or extreme hypotension,146 and several artifacts can appear in the ICU environment, this technique is still extensively used as an ancillary test in BD diagnosis. Buchner et al. proposed that its sensitivity as well as specificity can reach up to 90%.147 On the other hand, multimodality evoked potentials (MEP) and electroretinography (ERG) are highly resistant to drug intoxication and hypothermia, and have been shown to be reliable in the ICU environment.148–154 Owing to these features, a substantial interest in multimodality evoked potentials (MEPs) in BD has grown over the past two decades, and a wealth of data are now available in the literature.151,152,155–159 However, considered as single tests, they have their limitations and they are not included routinely as confirmatory tests for BD diagnosis.1,160 Hence, we have proposed to combine EEG, MEP, and ERG in a test battery to study brain-dead patients in order to increase diagnostic reliability.49,152,158,161–168
Therefore, an adequate medical practice would be to assess comatose patients by monitoring CBF by TCD, and neuronal function by the above mentioned neurophysiologic test battery. If TCD fails to validate the absence of CBF, CTA can be used to confirm BD diagnosis.1
Brain death and organ transplants
Although it is commonly believed that the concept of BD was developed to benefit organ transplants, it evolved independently. Transplantation owed its development to advances in surgery and immunosuppressive treatment; BD owed its origin to the development of intensive care. A historical review demonstrates that the BD concept and organ transplantation arose separately and advanced in parallel, and only began to progress together in the late 1960s.5–8,11,12,169,170 Of course, organ procurement programs have induced a tie relationship between organ transplants and BD diagnosis in most countries and, hence, it is extremely important to educate the public to understand that BD means death of the individual, and of the importance of organ donation for transplants.
Conclusions
BD should be understood as the ultimate clinical expression of a brain catastrophe leading to a complete and irreversible neurological stoppage, characterized by irreversible coma, absent brainstem reflexes, and apnea. We have enumerated three possible situations for diagnosing death based on the “signs of death”. This methodology of diagnosing death does not mean that there are different types of death. The irreversible loss of cardio-circulatory and respiratory functions can cause death only when ischemia and anoxia are prolonged enough to produce an irreversible destruction of the brain.
References
- 1.Machado C. Brain death. A reappraisal. New York: Springer. 2007:1–223. [Google Scholar]
- 2.Pallis C. Brainstem death--the evolution of a concept. Med Leg J. 1987;55:84–107. doi: 10.1177/002581728705500204. [DOI] [PubMed] [Google Scholar]
- 3.Pallis C. Brainstem death. In: Braakman R, editor. Handbook of Clinical Neurology: Head Injury. Vol 13. Amsterdam: Elsevier Science; 1990. pp. 441–96. [Google Scholar]
- 4.Pallis C. Further thoughts on brainstem death. Anaesth Intensive Care. 1995;23:20–3. doi: 10.1177/0310057X9502300105. [DOI] [PubMed] [Google Scholar]
- 5.Pallis C. Brainstem death: the evolution of a concept. Semin Thorac Cardiovasc Surg. 1990;2:135–52. [PubMed] [Google Scholar]
- 6.Wijdicks EF. Brain death worldwide: accepted fact but no global consensus in diagnostic criteria. Neurology. 2002;58:20–5. doi: 10.1212/wnl.58.1.20. [DOI] [PubMed] [Google Scholar]
- 7.Wijdicks EF. The neurologist and Harvard criteria for brain death. Neurology. 2003;61:970–6. doi: 10.1212/01.wnl.0000086804.18169.8d. [DOI] [PubMed] [Google Scholar]
- 8.Machado C, Shewmon DL. Brain Death and Disorders of Consciousness. Vol 50. New York; Kluwer Academics/Plenum: 2004. pp. 1–268. [Google Scholar]
- 9.Machado C. Havana and the coma and death symposia. N Engl J Med. 2004;351:1150–1. doi: 10.1056/NEJM200409093511122. [DOI] [PubMed] [Google Scholar]
- 10.Korein J, Machado C. Brain death --Updating a valid concept for 2004. Brain Death and Disorders of Consciousness. 2004;550:1–14. [PubMed] [Google Scholar]
- 11.Machado C. The first organ transplant from a brain-dead donor. Neurology. 2005;64:1938–42. doi: 10.1212/01.WNL.0000163515.09793.CB. [DOI] [PubMed] [Google Scholar]
- 12.Machado C. The concept of brain death did not evolve to benefit transplantation. Neurology. 2006;66:A2–A2. [Google Scholar]
- 13.Machado C, Korein J, Ferrer Y, et al. The concept of brain death did not evolve to benefit organ transplants. J Med Ethics. 2007;33:197–200. doi: 10.1136/jme.2006.016931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Machado C. The declaration of Sydney on death. Neurology. 2007;68:A6–A6. [Google Scholar]
- 15.Landmark article Aug 5, 1968: A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to examine the definition of brain death. J Am Med Assoc. 1984;252:677–9. [PubMed] [Google Scholar]
- 16.A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. J Am Med Assoc. 1968;205:337–40. [PubMed] [Google Scholar]
- 17.Walker AE, Molinari GF. Criteria of cerebral death. Trans Am Neurol Assoc. 1975;100:29–35. [PubMed] [Google Scholar]
- 18.Robert F, Mumenthaler M. Criteria of brain death Spinal reflexes in 45 personal studies. Schweiz Med Wochenschr. 1977;107:335–41. [PubMed] [Google Scholar]
- 19.Cranford RE. Minnesota Medical Association criteria Brain death: concept and criteria, II. Mo Med. 1978;61:600–3. [PubMed] [Google Scholar]
- 20.Pasnikowski W. Current criteria of brain death. Przegl Lek. 1987;44:672–5. [PubMed] [Google Scholar]
- 21.Jan MM. Brain death criteria The neurological determination of death. Neurosciences. 2008;13:350–5. [PubMed] [Google Scholar]
- 22.Wijdicks EFM. Clinical Diagnosis and Confirmatory Testing in Brain Death in Adults. In: Wijdicks EFM, editor. Brain Death. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 61–90. [Google Scholar]
- 23.Palmer S, Bader M. Brain tissue oxygenation in brain death. Neurosurgery. 2003;53:831–831. [Google Scholar]
- 24.Palmer S, Bader MK. Brain tissue oxygenation in brain death. Neurocritical Care. 2005;2:17–22. doi: 10.1385/NCC:2:1:017. [DOI] [PubMed] [Google Scholar]
- 25.Heran MKS, Heran NS, Shemie SD. A review of ancillary tests in evaluating brain death. Can J Neurol Sci. 2008;35:409–19. doi: 10.1017/s0317167100009069. [DOI] [PubMed] [Google Scholar]
- 26.Shimizu N, Shemie S, Miyasaka E, et al. Preliminary report: Use of clinical criteria for the determination of pediatric brain death and confirmation by radionuclide cerebral blood flow. Jpn J Anesthesiol. 2000;49:1126–32. [PubMed] [Google Scholar]
- 27.Young GB, Shemie SD, Doig CJ, et al. Brief review: the role of ancillary tests in the neurological determination of death. Can J Anaesth. 2006;53:620–7. doi: 10.1007/BF03021855. [DOI] [PubMed] [Google Scholar]
- 28.Shemie SD, Lee D, Sharpe M, et al. Brain blood flow in the neurological determination of death: Canadian expert report. Can J Neurol Sci. 2008;35:140–5. doi: 10.1017/s0317167100008544. [DOI] [PubMed] [Google Scholar]
- 29.Escudero D, Otero J, Vega P, et al. Diagnosis of brain death by multislice CT scan: angioCT scan and brain perfusion. Med Intensiva. 2007;31:335–41. doi: 10.1016/s0210-5691(07)74833-7. [DOI] [PubMed] [Google Scholar]
- 30.Kosteljanetz M, Ohrstrom JK, Skjodt S, et al. Clinical Brain-Death with Preserved Cerebral Arterial Circulation. Acta Neurol Scand. 1988;78:418–21. doi: 10.1111/j.1600-0404.1988.tb03679.x. [DOI] [PubMed] [Google Scholar]
- 31.Alvarez LA, Lipton RB, Hirschfeld A, et al. Brain death determination by angiography in the setting of a skull defect. Arch Neurol. 1988;45:225–7. doi: 10.1001/archneur.1988.00520260117031. [DOI] [PubMed] [Google Scholar]
- 32.Braun M, Ducrocq X, Huot JC, et al. Intravenous angiography in brain death: Report of 140 patients. Neuroradiology. 1997;39:400–5. doi: 10.1007/s002340050432. [DOI] [PubMed] [Google Scholar]
- 33.Hansen AVE, Lavin PJM, Moody EB, et al. False-negative cerebral radionuclide flow study, in brain-death, caused by a ventricular drain. Clin Nucl Med. 1993;18:502–5. doi: 10.1097/00003072-199306000-00009. [DOI] [PubMed] [Google Scholar]
- 34.van Leusen HJ, Tans JT, Wurzer JA. Hemicraniectomy for treatment of malignant medial cerebral artery infarction in 3 patients. Ned Tijdschr Geneeskd. 2001;145:639–43. [PubMed] [Google Scholar]
- 35.Pillai A, Menon SK, Kumar S, et al. Decompressive hemicraniectomy in malignant middle cerebral artery infarction: an analysis of long-term outcome and factors in patient selection. J Neurosurg. 2007;106:59–65. doi: 10.3171/jns.2007.106.1.59. [DOI] [PubMed] [Google Scholar]
- 36.Palmer S, Bader MK. Cerebral oxygenation. J Neurosurg. 2008;108:198–9. doi: 10.3171/JNS/2008/108/01/0198a. [DOI] [PubMed] [Google Scholar]
- 37.Miyazaki Y, Takamatsu H, Tanaka Y, et al. Criteria of cerebral death. Acta Radiol Diagn (Stockh) 1972;13:318–28. doi: 10.1177/02841851720130p140. [DOI] [PubMed] [Google Scholar]
- 38.Cranford RE. Brain death Concept and criteria. Minn Med. 1978;61:600–3. [PubMed] [Google Scholar]
- 39.Cranford RE. Minnesota Medical Association criteria. Brain death: concept and criteria, I. Mo Med. 1978;61:561–3. [PubMed] [Google Scholar]
- 40.Presidential commission urges states to add brain function criteria to definition of death. Ob Gyn News. 1981;16:24–5. [PubMed] [Google Scholar]
- 41.Kurdi A, Hijazi H. Criteria of brain death--a review. Middle East J Anesthesiol. 1987;9:149–61. [PubMed] [Google Scholar]
- 42.Payen D, Lamer C, Raggueneau JL, et al. Criteria for brain death: cessation of cerebral circulation demonstrated by Doppler ultrasonography of the carotid arteries. Bull Acad Natl Med. 1989;173:149–55. [PubMed] [Google Scholar]
- 43.Roosen K, Klein M. Criteria and diagnosis of brain death. Versicherungsmedizin. 1990;42:110–2. [PubMed] [Google Scholar]
- 44.Lang CJ. New criteria for brain death? J Neurol Neurosurg Psychiatry. 1991;54:1030–1. doi: 10.1136/jnnp.54.11.1030-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Machado-Curbelo C. A new formulation of death: Definition criteria and diagnostic tests. Rev Neurol. 1998;26:1040–7. [PubMed] [Google Scholar]
- 46.Zhang TX. [Imminent issues on clinical diagnostic criteria for brain death] Zhonghua Nei Ke Za Zhi. 2004;43:246–8. [PubMed] [Google Scholar]
- 47.Wijdicks EFM. Determining Brain-Death in adults. Neurology. 1995;45:1003–11. doi: 10.1212/wnl.45.5.1003. [DOI] [PubMed] [Google Scholar]
- 48.Machado C. Brain formulation of death: A reappraisal. Neurology. 1995;45:1097P–1097P. [Google Scholar]
- 49.Machado C. [Resolution for the determination and certification of death in Cuba] Rev Neurol. 2003;36:763–70. [PubMed] [Google Scholar]
- 50.Machado C, Abeledo M, Alvarez C, et al. Cuba has passed a law for the determination and certification of death. Adv Exp Med Biol. 2004;550:139–42. doi: 10.1007/978-0-306-48526-8_11. [DOI] [PubMed] [Google Scholar]
- 51.Machado C. Determination of death. Acta Anaesthesiol Scand. 2005;49:592–3. doi: 10.1111/j.1399-6576.2004.00584.x. [DOI] [PubMed] [Google Scholar]
- 52.Machado C. Variability of brain death determination guidelines in leading US neurologic institutions. Neurology. 2008;71:1125–1125. doi: 10.1212/01.wnl.0000334352.27463.49. [DOI] [PubMed] [Google Scholar]
- 53.Machado C, García-Tigera J, García O, et al. Muerte Encefálica. Criterios diagnósticos. Revista Cubana de Medicina. 1991;30:181–206. [Google Scholar]
- 54.Machado-Curbelo C. Do we defend a brain oriented view of death. Rev Neurol. 2002;35:387–96. [PubMed] [Google Scholar]
- 55.Wijdicks EF. The diagnosis of brain death. N Engl J Med. 2001;344:1215–21. doi: 10.1056/NEJM200104193441606. [DOI] [PubMed] [Google Scholar]
- 56.de Tourtchaninoff M, Hantson P, Mahieu P, et al. Brain death diagnosis in misleading conditions. Quart J Med. 1999;92:407–14. doi: 10.1093/qjmed/92.7.407. [DOI] [PubMed] [Google Scholar]
- 57.Ashwal S. Clinical Diagnosis and Confirmatory Testing of Brain Death in Children. In: Wijdicks EFM, editor. Brain Death. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 91–114. [Google Scholar]
- 58.Guidelines for the diagnosis of brain death. Canadian Neurocritical Care Group. Can J Neurol Sci. 1999;26:64–6. [PubMed] [Google Scholar]
- 59.Parker BL, Frewen TC, Levin SD, et al. Declaring pediatric brain death: current practice in a Canadian pediatric critical care unit. Can Med Assoc J. 1995;153:909–16. [PMC free article] [PubMed] [Google Scholar]
- 60.Death and brain death: a new formulation for Canadian medicine. Canadian Congress Committee on Brain Death. Can Med Assoc J. 1988;138:405–6. [PMC free article] [PubMed] [Google Scholar]
- 61.Wijdicks EF. The first organ transplant from a brain-dead donor. Neurology. 2006;66:460–1. doi: 10.1212/01.wnl.0000209204.87339.ef. [DOI] [PubMed] [Google Scholar]
- 62.Matesanz R. The diagnosis of brain death in Latin America. Med Intensiva. 2009;33:413–4. doi: 10.1016/j.medin.2009.07.006. [DOI] [PubMed] [Google Scholar]
- 63.Criteria for the diagnosis of brain stem death. Review by a working group convened by the Royal College of Physicians and endorsed by the Conference of Medical Royal Colleges and their Faculties in the United Kingdom. J R Coll Physicians Lond. 1995;29:381–2. [PMC free article] [PubMed] [Google Scholar]
- 64.An appraisal of the criteria of cerebral death. A summary statement. A collaborative study. J Am Med Assoc. 1977;237:982–6. doi: 10.1001/jama.1977.03270370054022. [DOI] [PubMed] [Google Scholar]
- 65.Wijdicks EF, Cranford RE. Clinical diagnosis of prolonged states of impaired consciousness in adults. Mayo Clin Proc. 2005;80:1037–46. doi: 10.4065/80.8.1037. [DOI] [PubMed] [Google Scholar]
- 66.Hansen PB, Thisted BK, Andersen LW, et al. Anesthesiologic aspects of multiorgan donation. Ugeskr Laeger. 1992;154:1172–6. [PubMed] [Google Scholar]
- 67.Vargas F, Hilbert G, Gruson D, et al. Fulminant Guillain-Barre syndrome mimicking cerebral death: case report and literature review. Intensive Care Med. 2000;26:623–7. doi: 10.1007/s001340051213. [DOI] [PubMed] [Google Scholar]
- 68.Shewmon DA. Recovery from “brain death”: a neurologist's apologia. Linacre Q. 1997;64:30–96. doi: 10.1080/20508549.1999.11878373. [DOI] [PubMed] [Google Scholar]
- 69.Bakshi N, Maselli RA, Gospe SM, Jr, et al. Fulminant demyelinating neuropathy mimicking cerebral death. Muscle Nerve. 1997;20:1595–7. doi: 10.1002/(sici)1097-4598(199712)20:12<1595::aid-mus17>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
- 70.Bohlega SA, Stigsby B, Haider A, et al. Guillain-Barre syndrome with severe demyelination mimicking axonopathy. Muscle Nerve. 1997;20:514–6. doi: 10.1002/(sici)1097-4598(199704)20:4<514::aid-mus19>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- 71.Coad NR, Byrne AJ. Guillain-Barre syndrome mimicking brainstem death. Anaesthesia. 1990;45:456–7. doi: 10.1111/j.1365-2044.1990.tb14333.x. [DOI] [PubMed] [Google Scholar]
- 72.Ostermann ME, Young B, Sibbald WJ, et al. Coma mimicking brain death following baclofen overdose. Intensive Care Med. 2000;26:1144–6. doi: 10.1007/s001340051330. [DOI] [PubMed] [Google Scholar]
- 73.Brenner RP. The interpretation of the EEG in stupor and coma. Neurologist. 2005;11:271–84. doi: 10.1097/01.nrl.0000178756.44055.f6. [DOI] [PubMed] [Google Scholar]
- 74.Marrache F, Megarbane B, Pirnay S, et al. Difficulties in assessing brain death in a case of benzodiazepine poisoning with persistent cerebral blood flow. Hum Exp Toxicol. 2004;23:503–5. doi: 10.1191/0960327104ht478cr. [DOI] [PubMed] [Google Scholar]
- 75.Sztajnkrycer MD, Huang EE, Bond GR. Acute zonisamide overdose: a death revisited. Vet Hum Toxicol. 2003;45:154–6. [PubMed] [Google Scholar]
- 76.Caballero F, Lopez-Navidad A, Cotorruelo J, et al. Ecstasy-induced brain death and acute hepatocellular failure: multiorgan donor and liver transplantation. Transplantation. 2002;74:532–7. doi: 10.1097/00007890-200208270-00017. [DOI] [PubMed] [Google Scholar]
- 77.Buylaert WA. Coma induced by intoxication. Acta Neurol Belg. 2000;100:221–4. [PubMed] [Google Scholar]
- 78.Burkhart KK, Kulig KW. The diagnostic utility of flumazenil (a benzodiazepine antagonist) in coma of unknown etiology. Ann Emerg Med. 1990;19:319–21. doi: 10.1016/s0196-0644(05)82054-2. [DOI] [PubMed] [Google Scholar]
- 79.Walker AE. Cerebral Death. 3rd ed. Baltimore-Munich: Urban & Schwarzenberg; 1985. pp. 1–198. [Google Scholar]
- 80.Saposnik G, Maurino J, Saizar R, et al. Spontaneous and reflex movements in 107 patients with brain death. Am J Med. 2005;118:311–4. doi: 10.1016/j.amjmed.2004.09.013. [DOI] [PubMed] [Google Scholar]
- 81.Wijdicks EFM. Brain Death. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 1–223. [Google Scholar]
- 82.Pallis C. ABC of brain stem death. Diagnosis of brain stem death--II. Br Med J (Clin Res Edn) 1982;285:1641–4. doi: 10.1136/bmj.285.6355.1641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Pallis C. ABC of brain stem death. Diagnosis of brain stem death--I. Br Med J (Clin Res Edn) 1982;285:1558–60. doi: 10.1136/bmj.285.6354.1558. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Walker AE. Dead or alive. J Nerv Ment Dis. 1984;172:639–41. doi: 10.1097/00005053-198411000-00001. [DOI] [PubMed] [Google Scholar]
- 85.Drory Y, Ouaknine G, Kosary IZ, et al. Electrocardiographic findings in brain death; description and presumed mechanism. Chest. 1975;67:425–32. doi: 10.1378/chest.67.4.425. [DOI] [PubMed] [Google Scholar]
- 86.Ouaknine GE, Mercier C. Value of the atropine test in the confirmation of brain death] Union Med Can. 1985;114:76–80. [PubMed] [Google Scholar]
- 87.Ouaknine GE. Cardiac and metabolic alterations in brain death: discussion paper. Ann NY Acad Sci. 1978;315:252–64. doi: 10.1111/j.1749-6632.1978.tb50343.x. [DOI] [PubMed] [Google Scholar]
- 88.Ouaknine G, Kosary IZ, Braham J, et al. Laboratory criteria of brain death. J Neurosurg. 1973;39:429–33. doi: 10.3171/jns.1973.39.4.0429. [DOI] [PubMed] [Google Scholar]
- 89.Ouaknine G, Kosary IZ, Ziv M. Value of the caloric test and electronystagmography in the diagnosis of irreversible coma. Neurochirurgie. 1973;19:407–14. [PubMed] [Google Scholar]
- 90.Zhang TX, Shi YJ, Sheng HQ, et al. Clinical diagnosis of 26 cases of brain death. Zhonghua Yi Xue Za Zhi. 2004;84:93–6. [PubMed] [Google Scholar]
- 91.Su YY, Zhao H, Zhang Y, et al. Studies on evaluation of brain death. Zhonghua Nei Ke Za Zhi. 2004;43:250–3. [PubMed] [Google Scholar]
- 92.Goila AK, Pawar M. The diagnosis of brain death. Indian J Crit Care Med. 2009;13:7–11. doi: 10.4103/0972-5229.53108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Huttemann E, Schelenz C, Sakka SG, et al. Atropine test and circulatory arrest in the fossa posterior assessed by transcranial Doppler. Intensive Care Med. 2000;26:422–5. doi: 10.1007/s001340051176. [DOI] [PubMed] [Google Scholar]
- 94.Goetting MG, Contreras E. Systemic atropine administration during cardiac arrest does not cause fixed and dilated pupils. Ann Emerg Med. 1991;20:55–7. doi: 10.1016/s0196-0644(05)81119-9. [DOI] [PubMed] [Google Scholar]
- 95.Cardan C, Roth A, Biro J. The atropine test in the assessment of brain death. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir. 1983;32:393–7. [PubMed] [Google Scholar]
- 96.Wijdicks EF, Manno EM, Holets SR. Ventilator self-cycling may falsely suggest patient effort during brain death determination. Neurology. 2005;65:774–774. doi: 10.1212/01.wnl.0000174626.94197.62. [DOI] [PubMed] [Google Scholar]
- 97.Lang CJ, Heckmann JG. Apnea testing for the diagnosis of brain death. Acta Neurol Scand. 2005;112:358–69. doi: 10.1111/j.1600-0404.2005.00527.x. [DOI] [PubMed] [Google Scholar]
- 98.Tsai WH, Lee WT, Hung KL. Determination of brain death in children-- a medical center experience. Acta Paediatr Taiwan. 2005;46:132–7. [PubMed] [Google Scholar]
- 99.Burns JM, Login IS. Confounding factors in diagnosing brain death: a case report. BMC Neurol. 2002;2:5–5. doi: 10.1186/1471-2377-2-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Melano R, Adum ME, Scarlatti A, et al. Apnea test in diagnosis of brain death: comparison of two methods and analysis of complications. Transplant Proc. 2002;34:11–2. doi: 10.1016/s0041-1345(01)02647-1. [DOI] [PubMed] [Google Scholar]
- 101.Vivien B, Haralambo MS, Riou B. Barotrama during apnea testing for the determination of brain death. Ann Fr Anesth Reanim. 2001;20:370–3. doi: 10.1016/s0750-7658(01)00379-3. [DOI] [PubMed] [Google Scholar]
- 102.Jeret JS. Complications during apnea testing in the determination of brain death: predisposing factors. Neurology. 2001;56:1249–1249. doi: 10.1212/wnl.56.9.1249. [DOI] [PubMed] [Google Scholar]
- 103.Rigg CD, Cruickshank S. Carbon dioxide during and after the apnoea test--an illustration of the Haldane effect. Anaesthesia. 2001;56:377–377. doi: 10.1046/j.1365-2044.2001.01976-10.x. [DOI] [PubMed] [Google Scholar]
- 104.Lessard M, Mallais R, Turmel A. Apnea test in the diagnosis of brain death. Can J Neurol Sci. 2000;27:353–4. [PubMed] [Google Scholar]
- 105.Goudreau JL, Wijdicks EF, Emery SF. Complications during apnea testing in the determination of brain death: predisposing factors. Neurology. 2000;55:1045–8. doi: 10.1212/wnl.55.7.1045. [DOI] [PubMed] [Google Scholar]
- 106.Machado C. National Commission for the Determination and Certification of Death. Resolution for the determination and certification of death in Cuba. Rev Neurol. 2003;36:763–70. [PubMed] [Google Scholar]
- 107.Okuyaz C, Gucuyener K, Karabacak NI, et al. Tc-99m-HMPAO SPECT in the diagnosis of brain death in children. Pediatr Int. 2004;46:711–4. doi: 10.1111/j.1442-200x.2004.01976.x. [DOI] [PubMed] [Google Scholar]
- 108.Mejia RE, Pollack MM. Variability in brain death determination practices in children. J Am Med Assoc. 1995;274:550–3. [PubMed] [Google Scholar]
- 109.Paret G, Barzilay Z. Apnea testing in suspected brain dead children--physiological and mathematical modelling. Intensive Care Med. 1995;21:247–52. doi: 10.1007/BF01701482. [DOI] [PubMed] [Google Scholar]
- 110.Chantarojanasiri T, Preutthipan A. Apnea documentation for determination of brain death in Thai children. J Med Assoc Thai. 1993;76:165–8. [PubMed] [Google Scholar]
- 111.Galaske RG, Schober O, Heyer R. Determination of brain death in children with 123I-IMP and Tc-99m HMPAO. Psychiatry Res. 1989;29:343–5. doi: 10.1016/0165-1781(89)90084-x. [DOI] [PubMed] [Google Scholar]
- 112.Bernat JL. On irreversibility as a prerequisite for brain death determination. Adv Exp Med Biol. 2004;550:161–7. doi: 10.1007/978-0-306-48526-8_14. [DOI] [PubMed] [Google Scholar]
- 113.Ingvar DH, Widen L. [Brain death. Summary of a symposium] Lakartidningen. 1972;69:3804–14. [PubMed] [Google Scholar]
- 114.Ingvar DH. Brain death--total brain infarction. Acta Anaesthesiol Scand Suppl. 1971;45:129–40. doi: 10.1111/j.1399-6576.1971.tb00668.x. [DOI] [PubMed] [Google Scholar]
- 115.Bucheler E, Kaufer C, Dux A. Cerebral angiography to determine brain death. Fortschr Geb Rontgenstr Nuklearmed. 1970;113:278–96. [PubMed] [Google Scholar]
- 116.Matricali B. Intracranial circulatory arrest. Minerva Neurochir. 1970;14:267–267. [PubMed] [Google Scholar]
- 117.Allais B, Vlahowitch , Du C, et al. Angiographic criteria of brain death. Anesth Analg (Paris) 1971;28:843–57. [PubMed] [Google Scholar]
- 118.Meyer MA. Evaluating brain death with positron emission tomography: case report on dynamic imaging of 18F-fluorodeoxyglucose activity after intravenous bolus injection. J Neuroimaging. 1996;6:117–9. doi: 10.1111/jon199662117. [DOI] [PubMed] [Google Scholar]
- 119.Laureys S, Owen AM, Schiff ND. Brain function in coma, vegetative state, and related disorders. Lancet Neurol. 2004;3:537–46. doi: 10.1016/S1474-4422(04)00852-X. [DOI] [PubMed] [Google Scholar]
- 120.Falini A, Barkovich AJ, Calabrese G, et al. Progressive brain failure after diffuse hypoxic ischemic brain injury: a serial MR and proton MR spectroscopic study. Am J Neuroradiol. 1998;19:648–52. [PMC free article] [PubMed] [Google Scholar]
- 121.Machado C, Rodriguez R, Carballo M, et al. Results of Proton MRS Studies in PVS and MCS Patients. Can J Neurol Sci. 2009;36:365–9. doi: 10.1017/s0317167100007137. [DOI] [PubMed] [Google Scholar]
- 122.Jonkman EJ, Mosmans PC. Doppler haematotachography: problems in interpretation and new applications. Clin Neurol Neurosurg. 1977;80:33–45. doi: 10.1016/s0303-8467(78)80005-5. [DOI] [PubMed] [Google Scholar]
- 123.Machado C. Assessment: Transcranial Doppler ultrasonography: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2004;63:2457–8. [PubMed] [Google Scholar]
- 124.Stulin ID, Sinkin MV. Current clinical and instrumental diagnosis of brain death. Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106:58–64. [PubMed] [Google Scholar]
- 125.Young GB, Shemie SD, Doig CJ, et al. Brief review: the role of ancillary tests in the neurological determination of death. Can J Anaesth. 2006;53:620–7. doi: 10.1007/BF03021855. [DOI] [PubMed] [Google Scholar]
- 126.Sardinha LAC, Araujo S, Boin IFSF. Brain death and transcranial Doppler ultrasound as exam for confirming test and its applicability in potential donors. Transpl Int. 2007;20:346–346. [Google Scholar]
- 127.Calderon CV, Portela PC. Recommendations of the transcranial Doppler in the diagnosis of brain death. Neurologia. 2008;23:397–8. [PubMed] [Google Scholar]
- 128.Conti A, Iacopino DG, Spada A, et al. Transcranial doppler ultrasonography in the assessment of cerebral circulation arrest: improving sensitivity by trancervical and transorbital carotid insonation and serial examinations. Neurocritical Care. 2009;10:326–35. doi: 10.1007/s12028-009-9199-7. [DOI] [PubMed] [Google Scholar]
- 129.Perez-Nellar J, Scherle C, Machado C. TCD systolic spikes in a malignant MCA infarct. Neurocrit Care. 2009;11:94–6. doi: 10.1007/s12028-009-9216-x. [DOI] [PubMed] [Google Scholar]
- 130.Sloan MA, Alexandrov AV, Tegeler CH, et al. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2004;62:1468–81. doi: 10.1212/wnl.62.9.1468. [DOI] [PubMed] [Google Scholar]
- 131.Martinelli O, Benedetti-Valentini F. Trancranial Doppler: value in clinical practice. Int Angiol. 2009;8:249–53. [PubMed] [Google Scholar]
- 132.Escudero D. [Brain death diagnosis] Med Intensiva. 2009;33:185–95. doi: 10.1016/s0210-5691(09)71215-x. [DOI] [PubMed] [Google Scholar]
- 133.Greer DM, Strozyk D, Schwamm LH. False positive CT angiography in brain death. Neurocritical Care. 2009;11:272–5. doi: 10.1007/s12028-009-9220-1. [DOI] [PubMed] [Google Scholar]
- 134.Wertheimer P, Jouvet M, Descotes J. Diagnosis of death of the nervous system in comas with respiratory arrest treated by artificial respiration. Presse Med. 1959;67:87–8. [PubMed] [Google Scholar]
- 135.Mollaret P, Goulon M. Coma dépassé (preliminary memoir) Rev Neurol (Paris) 1959;101:3–15. [PubMed] [Google Scholar]
- 136.Pallis C. Danish ethics council rejects brain death as the criterion of death --commentary 2: return to Elsinore. J Med Ethics. 1990;16:10–3. doi: 10.1136/jme.16.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Connie FO, Kelvin LK, Chung AC, et al. Knowledge, acceptance and perception towards brainstem death among medical students in Hong Kong: a questionnaire survey on brainstem death. Med Teach. 2008;30:e125–30. doi: 10.1080/01421590801932236. [DOI] [PubMed] [Google Scholar]
- 138.Pallis C. Defining death. Br Med J (Clin Res Ed) 1985;291:666–7. [PMC free article] [PubMed] [Google Scholar]
- 139.Pallis C. ABC of brain stem death. The arguments about the EEG. Br Med J (Clin Res Ed) 1983;286:284–7. doi: 10.1136/bmj.286.6361.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Rodin E, Tahir S, Austin D, et al. Brainstem death. Clin Electroencephalogr. 1985;16:63–71. doi: 10.1177/155005948501600202. [DOI] [PubMed] [Google Scholar]
- 141.Bernat JL, Culver CM, Gert B. On the definition and criterion of death. Arch Intern Med. 1981;94:389–94. doi: 10.7326/0003-4819-94-3-389. [DOI] [PubMed] [Google Scholar]
- 142.Bernat JL, Culver CM, Gert B. Definition of death. Ann Intern Med. 1981;95:652–652. doi: 10.7326/0003-4819-95-5-652_1. [DOI] [PubMed] [Google Scholar]
- 143.Bernat JL. The biophilosophical basis of whole-brain death. Soc Philos Policy. 2002;19:324–42. doi: 10.1017/s0265052502192132. [DOI] [PubMed] [Google Scholar]
- 144.Bohatyrewicz R, Bohatyrewicz A, Zukowski M, et al. Reversal to whole-brain death criteria after 15-year experience with brainstem death criteria in Poland. Transplant Proc. 2009;41:2959–60. doi: 10.1016/j.transproceed.2009.07.079. [DOI] [PubMed] [Google Scholar]
- 145.Bernat JL. The concept and practice of brain death. Prog Brain Res. 2005;150:369–79. doi: 10.1016/S0079-6123(05)50026-8. [DOI] [PubMed] [Google Scholar]
- 146.Chatrian GE. Electrophysiologic evaluation of brain death: A critical appraisal. In: Aminoff MJ, editor. Electrodiagnosis in Clinical Neurology. New York: Churchill Livingstone; 1980. pp. 525–88. [Google Scholar]
- 147.Buchner H, Schuchardt V. Reliability of electroencephalogram in the diagnosis of brain death. Eur Neurol. 1990;30:138–41. doi: 10.1159/000117330. [DOI] [PubMed] [Google Scholar]
- 148.Cobb WA, Dawson GD. The latency and form in man of the occipital potentials evoked by bright flashes. J Physiol. 1960;152:108–21. doi: 10.1113/jphysiol.1960.sp006474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Neumann N, Kotchoubey B. Assessment of cognitive functions in severely paralysed and severely brain-damaged patients: neuropsychological and electrophysiological methods. Brain Res Protoc. 2004;14:25–36. doi: 10.1016/j.brainresprot.2004.09.001. [DOI] [PubMed] [Google Scholar]
- 150.Rothstein TL. Recovery from near death following cerebral anoxia: A case report demonstrating superiority of median somatosensory evoked potentials over EEG in predicting a favorable outcome after cardiopulmonary resuscitation. Resuscitation. 2004;60:335–41. doi: 10.1016/j.resuscitation.2003.10.007. [DOI] [PubMed] [Google Scholar]
- 151.Facco E, Machado C. Evoked potentials in the diagnosis of brain death. Adv Exp Med Biol. 2004;550:175–87. doi: 10.1007/978-0-306-48526-8_16. [DOI] [PubMed] [Google Scholar]
- 152.Machado C. Evoked potentials in brain death. Clin Neurophysiol. 2004;115:238–9. doi: 10.1016/s1388-2457(03)00256-6. [DOI] [PubMed] [Google Scholar]
- 153.Guerit JM. Evoked potentials in severe brain injury. Prog Brain Res. 2005;150:415–26. doi: 10.1016/S0079-6123(05)50029-3. [DOI] [PubMed] [Google Scholar]
- 154.Wang K, Yuan Y, Xu ZQ, et al. Benefits of combination of electroencephalography, short latency somatosensory evoked potentials, and transcranial Doppler techniques for confirming brain death. J Zhejiang University-Sci B. 2008;9:916–20. doi: 10.1631/jzus.B0820123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 155.Sasaki M, Sakamoto T, Yamashita M, et al. Auditory evoked brain-stem responses (ABRs) in brain dead status. No To Shinkei. 1984;36:917–24. [PubMed] [Google Scholar]
- 156.Borel C, Hanley D. Neurologic intensive care unit monitoring. Crit Care Clin. 1985;1:223–39. [PubMed] [Google Scholar]
- 157.Erbengi A, Erbengi G, Cataltepe O, et al. Brain death: determination with brain stem evoked potentials and radionuclide isotope studies. Acta Neurochir (Wien) 1991;112:118–25. doi: 10.1007/BF01405139. [DOI] [PubMed] [Google Scholar]
- 158.Machado C, García-Tigera J, Coutin P. Multimodality evoked potentials and electroretinography in a test battery for the early diagnosis of brain death. Electroenceph Clin Neurophysiol. 1991;79:S19–S19. [Google Scholar]
- 159.Su YY, Yang QL, Pang Y, et al. Evaluation of coma patients after cardiopulmonary resuscitation. Chin Med J (Engl) 2005;118:1808–11. [PubMed] [Google Scholar]
- 160.Machado-Curbelo C, Roman-Murga JM. Usefulness of multimodal evoked potentials and the electroretinogram in the early diagnosis of brain death. Rev Neurol. 1998;27:809–17. [PubMed] [Google Scholar]
- 161.Machado C, Pumariega J, García-Tigera J, et al. A multimodal evoked potential and electroretinography test battery for the early diagnosis of brain death. Int J Neurosci. 1989;49:241–2. [Google Scholar]
- 162.Machado C. Visual evoked potentials and electroretinography in brain-dead patients. Neurophysiologie Clinique. 1990;20:18s–18s. doi: 10.1007/BF01203286. [DOI] [PubMed] [Google Scholar]
- 163.Machado C, Valdes P, Garciatigera J, et al. Brain-Stem Auditory Evoked-Potentials and Brain-Death. Electroencephalogr Clin Neurophysiol. 1991;80:392–8. doi: 10.1016/0168-5597(91)90087-e. [DOI] [PubMed] [Google Scholar]
- 164.Machado C. Multimodality evoked potentials and electroretinography in a test battery for an early diagnosis of brain death. J Neurosurg Sci. 1993;37:125–31. [PubMed] [Google Scholar]
- 165.Machado C, Santiesteban R, Garcia O, et al. Visual evoked potentials and electroretinography in brain-dead patients. Doc Ophthalmol. 1993;84:89–96. doi: 10.1007/BF01203286. [DOI] [PubMed] [Google Scholar]
- 166.Machado C. Brain death diagnosis. Acta Medica Medianae. 2009;48:41–6. [Google Scholar]
- 167.Machado C, Valdes P, Garcia O, et al. Short latency somatosensory evoked potentials in brain-dead patients using restricted low cut filter setting. J Neurosurg Sci. 1993;37:133–40. [PubMed] [Google Scholar]
- 168.Machado-Curbelo C. A new formulation of death: definition, criteria and diagnostic tests. Rev Neurol. 1998;26:1040–7. [PubMed] [Google Scholar]
- 169.Machado C. The first organ transplant from a brain-dead donor - Reply. Neurology. 2006;66:461–461. doi: 10.1212/01.wnl.0000209204.87339.ef. [DOI] [PubMed] [Google Scholar]
- 170.Machado C, Korein J. Neuropathology of brain death in the modern transplant era. Neurology. 2009;72:1028–1028. doi: 10.1212/01.wnl.0000339394.33719.76. [DOI] [PubMed] [Google Scholar]